SOGECE
Board
2 directors, last change in 2025Director (not named in the articles)
since 20-11-2025
6-year term from 2025
earlier manager, until 28-11-2025
listed in the 2025 annual accounts, filed on 31-08-2026
Director (not named in the articles)
since 20-11-2025
6-year term from 2025
earlier manager, until 28-11-2025
listed in the 2025 annual accounts, filed on 31-08-2026
Mandates through the years
2 names, the dashed line is todayDirector (not named in the articles)
Director (not named in the articles)
BoardEarlierRest of the termmandate already running before its first mention
Mandates as a list
-
- Director (not named in the articles), from 22-05-1999 to date
- Manager, until 28-11-2025
-
- Manager, appointed by deed of 06-01-2016, until 28-11-2025
- Director (not named in the articles), appointed by deed of 28-11-2025, still in office
Control
Founder
This company
SOGECE
Equity €497,095
Profit €100,929 in 2025
Capital
- Contribution
- €6,205.32
- Shares
- 750
- Contribution per share
- €8.27
- Equity per share
- €663 in 2025
- Source
- 2025 annual accounts
Articles of association
deed of 28-11-2025 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
- “Prescrits du Code des Sociétés et respect du Code de Déontologie Médicale, liquidateurs non habilités à exercer l'art de guérir assistés par…”
Shareholders
At incorporation
deed of 03-04-2019 ↗
- all shares
Capital transactions
Capital over time
- 28-11-2025 Capital stated in the deed · 750 shares
- 03-04-2019 Capital reduction of €162,000 · to €18,600 · repaid to the shareholders
- 03-04-2019 Incorporation · BEF 750,000 · 750 shares
- 03-04-2019 Capital increase · to €18,600 · from reserves
- 03-04-2019 Capital increase of €162,000 · to €180,600 · no new shares · in cash